Anixa Biosciences, Inc. ANIX
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.86M | 13.69M | 14.20M | 15.17M | 16.03M |
| Total Receivables | -- | 56.00K | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.05M | 950.00K | 848.00K | 713.00K | 1.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.91M | 14.69M | 15.05M | 15.89M | 17.45M |
|
|
|||||
| Total Current Assets | 14.91M | 14.69M | 15.05M | 15.89M | 17.45M |
| Net Property, Plant & Equipment | 163.00K | 173.00K | 183.00K | 193.00K | 202.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 15.07M | 14.87M | 15.23M | 16.08M | 17.65M |
|
|
|||||
| Total Accounts Payable | 282.00K | 252.00K | 148.00K | 165.00K | 276.00K |
| Total Accrued Expenses | 1.42M | 1.21M | 1.05M | 1.76M | 1.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 46.00K | 44.00K | 42.00K | 41.00K | 39.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.75M | 1.50M | 1.24M | 1.97M | 2.07M |
|
|
|||||
| Total Current Liabilities | 1.75M | 1.50M | 1.24M | 1.97M | 2.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 128.00K | 140.00K | 151.00K | 163.00K | 174.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.87M | 1.64M | 1.39M | 2.13M | 2.24M |
|
|
|||||
| Common Stock & APIC | 273.84M | 271.23M | 269.32M | 266.84M | 265.58M |
| Retained Earnings | -259.36M | -256.76M | -254.24M | -251.68M | -248.98M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 14.47M | 14.48M | 15.08M | 15.16M | 16.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.47M | 14.48M | 15.08M | 15.16M | 16.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.27M | -1.25M | -1.23M | -1.21M | -1.18M |
| Total Equity | 13.20M | 13.22M | 13.85M | 13.95M | 15.41M |
|
|
|||||